Concepedia

Kalyan Chakravarthy

KC

7

Publications

173

Citations

7

H-Index

2010

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Quantitative BioSciences

Kalyan Chakravarthy is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in biomedical imaging, medical imaging, and biomedical engineering.

Top concepts

Publications per year

2010–2021

7

Publications

7

Evaluation of JAK3 Biology in Autoimmune Disease Using a Highly Selective, Irreversible JAK3 Inhibitor

Fiona Elwood, David J. Witter, Jennifer Piesvaux et al. · Journal of Pharmacology and Experimental Therapeutics · 2017 · 32 citations

Discovery and Optimization of Rationally Designed Bicyclic Inhibitors of Human Arginase to Enhance Cancer Immunotherapy

Matthew J. Mitcheltree, Derun Li, Abdelghani Achab et al. · ACS Medicinal Chemistry Letters · 2020 · 30 citations · Full text

Cold Spark Discharge Plasma Treatment of Inflammatory Bowel Disease in an Animal Model of Ulcerative Colitis

Kalyan Chakravarthy, Danil Dobrynin, Gregory Fridman et al. · Plasma Medicine · 2010 · 28 citations · Full text

Development and optimization of a high-throughput micro-computed tomography imaging method incorporating a novel analysis technique to evaluate bone mineral density of arthritic joints in a rodent model of collagen induced arthritis

Raquel Sevilla, Francisco Cruz, Chi‐Sung Chiu et al. · Bone · 2014 · 27 citations · Full text

, , +19

Structure-Based Discovery of Proline-Derived Arginase Inhibitors with Improved Oral Bioavailability for Immuno-Oncology

Min Lu, Hongjun Zhang, Derun Li et al. · ACS Medicinal Chemistry Letters · 2021 · 22 citations · Full text

Rows per page

1–5 of 7